Clinical trial

Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma

NCT03393858

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2017-12-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2017-12-01Date precision: day

Registry last updated2024-02-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancerunresolved

Mesothelioma, Malignantunresolved

Interventions

Anti-PD-1 antibodyDRUG

DC-CIK ImmunotherapyBIOLOGICAL

Thermotron RF-8EXDEVICE

Sponsors & collaborators

Capital Medical Universitylead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03393858 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.